title: Effect of testosterone on bone in hypogonadal males.
abstract: Bone mineral content (BMC) and testosterone levels were evaluated and compared in 10 hypogonadal males and 10 normal, age-matched controls. In 6 of the subjects an investigation was also carried out into the effects of testosterone administration on lumbar BMC, calcitonin (CT) response to hypercalcaemia, osteocalcin (BGP) and the fasting urinary calcium/creatinine and hydroxyproline/creatinine ratios. Our results confirm that male hypogonadism is characterized by a low BMC and that testosterone administration is able to improve this parameter and to increase both basal BGP and CT response to hypercalcaemia. Testosterone therefore probably acts on bone tissue through both a direct action on osteoblast cells and an improvement in CT secretion.
authors.affiliation: Clinica Medica B, University of Turin, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Isaia
authors.forename: M
authors.initials: M
authors.lastname: Mussetta
authors.forename: F
authors.initials: F
authors.lastname: Pecchio
authors.forename: A
authors.initials: A
authors.lastname: Sciolla
authors.forename: M
authors.initials: M
authors.lastname: di Stefano
authors.forename: G M
authors.initials: GM
authors.lastname: Molinatti
mesh_terms: D000328:Adult; D015519:Bone Density / Q000187:drug effects*; D002116:Calcitonin / Q000097:blood; D004338:Drug Combinations; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D015675:Osteocalcin / Q000097:blood; D010281:Parathyroid Hormone / Q000097:blood; D013739:Testosterone / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D010281:Parathyroid Hormone; D015675:Osteocalcin; D013739:Testosterone; D002116:Calcitonin